檢索結果 - Morschhauser, Franck

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma 由 Gribben, John G., Fowler, Nathan, Morschhauser, Franck

獲取全文 獲取全文 獲取全文

Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma 由 Cartron, Guillaume, Hourcade-Potelleret, Florence, Morschhauser, Franck, Salles, Gilles, Wenger, Michael, Truppel-Hartmann, Anna, Carlile, David J.

獲取全文 獲取全文 獲取全文

(18)F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome 由 Cottereau, Anne-Ségolène, Nioche, Christophe, Dirand, Anne-Sophie, Clerc, Jérôme, Morschhauser, Franck, Casasnovas, Olivier, Meignan, Michel, Buvat, Irène

獲取全文 獲取全文 獲取全文

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059) 由 Rule, Simon A., Cartron, Guillaume, Fegan, Christopher, Morschhauser, Franck, Han, Lingling, Mitra, Siddhartha, Salles, Gilles, Dyer, Martin J. S.

獲取全文 獲取全文 獲取全文

Detection of Non-Hodgkin’s Lymphoma in ovarian cortex pieces during the process of cryopreservation 由 Gronier, Héloïse, Terriou, Louis, Robin, Geoffroy, Wacrenier, Agnès, Leroy-Martin, Brigitte, Lefebvre, Catherine, Vinatier, Denis, Morschhauser, Franck, Decanter, Christine

獲取全文 獲取全文 獲取全文

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment 由 Vo, Dang-Nghiem, Alexia, Catherine, Allende-Vega, Nerea, Morschhauser, Franck, Houot, Roch, Menard, Cedric, Tarte, Karin, Cartron, Guillaume, Villalba, Martin

獲取全文 獲取全文 獲取全文

Controversies in the Treatment of Peripheral T-cell Lymphoma 由 Bachy, Emmanuel, Broccoli, Alessandro, Dearden, Claire, de Leval, Laurence, Gaulard, Philippe, Koch, Raphael, Morschhauser, Franck, Trümper, Lorenz, Zinzani, Pier Luigi

獲取全文 獲取全文 獲取全文

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma 由 Morschhauser, Franck, Salles, Gilles, Le Gouill, Steven, Tilly, Herve, Thieblemont, Catherine, Bouabdallah, Krimo, Fabiani, Bettina, Ménard, Cédric, Tarte, Karin, Cartron, Guillaume, Houot, Roch

獲取全文 獲取全文 獲取全文

Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study gr... 由 Sibon, David, Morschhauser, Franck, Resche-Rigon, Matthieu, Ghez, David, Dupuis, Jehan, Marçais, Ambroise, Deau-Fischer, Bénédicte, Bouabdallah, Reda, Sebban, Catherine, Salles, Gilles, Brice, Pauline

獲取全文 獲取全文 獲取全文

Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial 由 Morschhauser, Franck, Ghosh, Nilanjan, Lossos, Izidore S., Palomba, M. Lia, Mehta, Amitkumar, Casasnovas, Olivier, Stevens, Don, Katakam, Sudhakar, Knapp, Andrea, Nielsen, Tina, McCord, Ron, Salles, Gilles

獲取全文 獲取全文 獲取全文

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30(+) Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient... 由 Perrot, Aurore, Monjanel, Hélène, Bouabdallah, Réda, Quittet, Philippe, Sarkozy, Clémentine, Bernard, Marc, Stamatoullas, Aspasia, Borel, Cécile, Bouabdallah, Krimo, Nicolas-Virelizier, Emmanuelle, Fournier, Marion, Morschhauser, Franck, Brice, Pauline

獲取全文 獲取全文 獲取全文

Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma 由 Ménard, Cédric, Rossille, Delphine, Dulong, Joelle, Nguyen, Tien-Tuan, Papa, Ilenia, Latour, Maelle, Bescher, Nadège, Bezier, Isabelle, Chouteau, Myriam, Fest, Thierry, Houot, Roch, Morschhauser, Franck, Tarte, Karin

獲取全文 獲取全文 獲取全文

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial 由 Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S., Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C., Zelenetz, Andrew D.

獲取全文 獲取全文 獲取全文

Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas 由 Revailler, Wendy, Cottereau, Anne Ségolène, Rossi, Cedric, Noyelle, Rudy, Trouillard, Thomas, Morschhauser, Franck, Casasnovas, Olivier, Thieblemont, Catherine, Le Gouill, Steven, André, Marc, Ghesquieres, Herve, Ricci, Romain, Meignan, Michel, Kanoun, Salim

獲取全文 獲取全文 獲取全文

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study 由 Ribrag, Vincent, Kim, Won Seog, Bouabdallah, Reda, Lim, Soon Thye, Coiffier, Bertrand, Illes, Arpad, Lemieux, Bernard, Dyer, Martin J. S., Offner, Fritz, Felloussi, Zakia, Kloos, Ioana, Luan, Ying, Vezan, Remus, Graef, Thorsten, Morschhauser, Franck

獲取全文 獲取全文 獲取全文

The landscape of new drugs in lymphoma 由 Younes, Anas, Ansell, Stephen, Fowler, Nathan, Wilson, Wyndham, de Vos, Sven, Seymour, John, Advani, Ranjana, Forero, Andres, Morschhauser, Franck, Kersten, Marie Jose, Tobinai, Kensei, Zinzani, Pier Luigi, Zucca, Emanuele, Abramson, Jeremy, Vose, Julie

獲取全文 獲取全文 獲取全文

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group 由 Bonnet, Christophe, Dupuis, Jehan, Tilly, Hervé, Lamy, Thierry, Fruchart, Christophe, le Gouill, Steven, Thieblemont, Catherine, Morschhauser, Franck, Casasnovas, Olivier, Bouabdallah, Krimo, Ghesquieres, Hervé, Van Den Neste, Eric, André, Marc, Cartron, Guillaume, Salles, Gilles

獲取全文 獲取全文 獲取全文

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma 由 Pro, Barbara, Horwitz, Steven M., Prince, H. Miles, Foss, Francine M., Sokol, Lubomir, Greenwood, Matthew, Caballero, Dolores, Morschhauser, Franck, Wilhelm, Martin, Iyer, Swaminathan Padmanabhan, Shustov, Andrei R., Wolfson, Julie, Balser, Barbara E., Coiffier, Bertrand

獲取全文 獲取全文 獲取全文

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA 由 Delfau-Larue, Marie-Hélène, de Leval, Laurence, Joly, Bertrand, Plonquet, Anne, Challine, Dominique, Parrens, Marie, Delmer, Alain, Salles, Gilles, Morschhauser, Franck, Delarue, Richard, Brice, Pauline, Bouabdallah, Reda, Casasnovas, Olivier, Tilly, Hervé, Gaulard, Philippe, Haioun, Corinne

獲取全文 獲取全文 獲取全文

Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma 由 Chiu, Hsiling, Trisal, Preeti, Bjorklund, Chad, Carrancio, Soraya, Toraño, Estela G., Guarinos, Carla, Papazoglou, Despoina, Hagner, Patrick R., Beldi‐Ferchiou, Asma, Tarte, Karin, Delfau‐Larue, Marie‐Hélène, Morschhauser, Franck, Ramsay, Alan G., Gandhi, Anita K.

獲取全文 獲取全文 獲取全文